24J-96538-19147 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-29
Registered in v-safe
2022-10-11
Dose 1 — Moderna
2022-11-08
Dose 2 — Moderna
2022-11-09
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Fever · Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-10
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-11
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Loss of appetite, Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-12
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-13
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Sleepiness, Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-14
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Irritability/crying, Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-15
Health check-in — day 7, dose 2, under 3
Feeling: Fair · Rash, not including the immediate area around the injection site

Under 3 check-in
2022-11-22
Survey response — day 14, dose 2, under 3
MedDRA: Cough, Respiratory tract congestion — Feeling: Fair

Free text: Coughing, congested

MedDRA releases: 2024-11 · check-in free text available
2022-11-29
Health check-in — day 21, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-12-06
Survey response — day 28, dose 2, under 3
MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Stuffy, running nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-12-13
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-20
Health check-in — day 42, dose 2, under 3
Feeling: Fair

Under 3 check-in
2023-02-07
Survey response — 3 months, dose 2, under 3
MedDRA: Bronchiolitis, Ear infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-02-07
Report sent to call center — 3 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-02-08
Call 1 — Left Voicemail
2023-05-09
Survey response — 6 months, dose 2, under 3
MedDRA: Gastroenteritis viral — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-10-11	Moderna	No
2	2022-11-08	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-11-22

Symptoms: Coughing, congested

Release 12 (Under 3) — day 28, dose 2, under 3

2022-12-06

Symptoms: Stuffy, running nose, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bronchiolitis	·	·	✓
SD	Cough	·	·	✓
SD	Ear infection	·	·	✓
SD	Gastroenteritis viral	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release